(+)-冰片|T5734|TargetMol

(+)-BORNEOL
464-43-7

￥190 50mg 起订

上海更新日期：2024-09-24

TargetMol中国（陶术生物）

VIP12年

联系人：邵小姐

电话：021-021-33632979拨打

手机：15002134094 拨打

邮箱：marketing@targetmol.com

产品详情:

中文名称：: (+)-冰片

英文名称：: (+)-BORNEOL

CAS号：: 464-43-7

品牌：: TargetMol

产地：: 美国

保存条件：: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

纯度规格：: ≥95%

产品类别：: 抑制剂

货号：: T5734

Product Introduction

Bioactivity

Name	(+)-BORNEOL
Description	(+)-BORNEOL (d-Borneol) is a natural bicyclic monoterpene used for analgesia and anesthesia in traditional Chinese medicine; enhances GABA receptor activity with an EC50 of 248 μM.
Cell Research	Oxidative stress was induced by administering 50 μM Aβ into SH-SY5Y cells. Neuroprotective effect of commercially available borneol was examined by determining cell viability with the MTT assay. Intracellular reactive oxygen species (ROS) generation was measured using a fluorometer with further examination of heme oxygenase-1 (HO-1) and nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) expression. Apoptosis was examined by measuring the ratio of B-cell lymphoma 2 (Bcl-2)/Bcl-2-associated X protein (Bax)[1].
Animal Research	To mimic a typical human stroke, which does not undergo reperfusion, used a permanent MCAO in this study. For investigating the role of (+)-borneol in permanent cerebral ischemia, 45 male Sprague-Dawley rats were randomly divided into the sham group, the vehicle-treated group and the (+)-borneol-treated groups (1.0 mg/kg), with 15 rats in each group. The terminal half-life (t1/2) of borneol was 2 h following cerebral ischemia-reperfusion. We subjected the rats to pMCAO and administered drugs by tail intravenous injection 2 hours and 5 hours after pMCAO, respectively. The sham group and the vehicle-treated group were injected with vehicle administration. Neurologic scores were assessed at 48 hours after reperfusion[2].
In vitro	Aβ诱导的细胞毒性被100μM的(-)和(+)-BORNEOL处理所抑制。冰片处理显著降低了ROS的生成（P < 0.01）。Aβ处理增加了HO-1的表达和Nrf2的核内转移。这种Nrf2的核内转移通过冰片的给药进一步增加。与仅Aβ处理的组相比，(+)-BORNEOL处理的组显著增加了Bcl-2的表达，并降低了Bax的表达[1]。
In vivo	(+)-borneol（1.0 mg/kg）通过降低诱导型一氧化氮合酶（iNOS）和肿瘤坏死因子-α（TNF-α）的表达，以剂量依赖的方式显著改善梗塞大小和神经评分。值得注意的是，在光栓塞模型的中风中，(+)-borneol展示了对感觉运动功能改善的长期效果，这通过减少树突棘在长度、分支数量和密度上的损失，至少在一定程度上降低了格栅行走任务中的脚失误数量和圆筒任务中的前肢不对称评分。这表明(+)-borneol可以作为缺血性中风的治疗靶标[2]。
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	DMSO : 100 mg/mL (648.30 mM)
Keywords	(+)BORNEOL \| BORNEOL \| (+) BORNEOL
Inhibitors Related	Penicillin G sodium salt \| Valproic acid sodium salt \| Valproic Acid \| DL-Menthol \| (-)-α-Pinene \| Nikethamide \| Riluzole \| Chlorothymol \| Halothane \| Gabapentin
Related Compound Libraries	Bioactive Compound Library \| Bioactive Compounds Library Max \| Ancient Chinese Classical Formulas Compound Library \| Food as Medicine Compound Library \| Ion Channel Targeted Library \| Natural Product Library \| Anti-Neurodegenerative Disease Compound Library \| Membrane Protein-targeted Compound Library \| Pain-Related Compound Library \| Natural Product Library for HTS

d-Borneol|||(+)-冰片|TargetMol

上海陶术生物科技有限公司为美国Target Molecule Corp. ( Target Mol ) 在上海建立的全资子公司。我们与美国波士顿、德国慕尼黑的同事一起，为北美、欧洲和亚洲从事药物研发和生物学研究的科学家提供优质的产品和专业的服务。公司下设筛选事业部，化学事业部，生物事业部和新材料部。从虚拟筛选到实体化合物分子供应；从商业化产品销售到个性化定制合成；从对明确靶点的分子筛选到对明确分子的多靶点筛选，从高通量筛选到化学结构优化，我们都可以满足您的科研用品及技术服务的需求。经过在中国市场五年的精心耕耘，我们已成为筛选化合物领域优秀的供应商，为超过五百家学校和各类企业提供了品质卓越的小分子化合物和药物筛

成立日期	(12年)
注册资本	566.2651万人民币
员工人数	100-500人
年营业额	￥ 1亿以上
经营模式	贸易,试剂,定制,服务
主营行业	化学试剂,生物活性小分子